Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263341 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
A Phase 3 study, sponsored by Population Council.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,135
- Enrollment target
NCT00263341 is a Phase 3 study that has completed, run by Population Council. The registered enrollment target is 1,135 participants.
The verdict
NCT00263341, a Phase 3 study, has completed, sponsored by Population Council.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,135 participants
- Enrollment target
Study Summary
The purpose of this 1-year study is to evaluate the efficacy and safety of a new contraceptive vaginal ring (CVR) delivering low doses of Nestorone (NES), a new, nonandrogenic progestin, and ethinyl estradiol (EE), an estrogen used in oral contraceptives. The CVR, which is made of silicone rubber, is designed to be used for 1 year (13 menstrual cycles) before replacement is required.
Interventions
- COMBINATION_PRODUCT NES/EE CVR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,135 participants |
| Start Date | 2005-12 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00263341
The ClinicalTrials.gov registry entry for NCT00263341 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Council, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NES/EE CVR is the first listed.
NCT00263341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00263341 about?
NCT00263341 is a clinical study titled "Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol". The purpose of this 1-year study is to evaluate the efficacy and safety of a new contraceptive vaginal ring (CVR) delivering low doses of Nestorone (NES), a new, nonandrogenic progestin, and ethinyl estradiol (EE), an estrogen used in oral contraceptives. The CVR, which is made of silicone rubber, i...
What is the current status of trial NCT00263341?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,135 participants. The study started on 2005-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00263341?
The interventions under investigation include: NES/EE CVR (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00263341?
This trial is sponsored by Population Council, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.